Andrew Benedict, OD
Optometrist · Blue Springs, MONPI 1962943399
Payments from drug & device makers
Across 118 payments — averaging $36.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Coopervision Inc.$620
- Alcon$612
- Bausch & Lomb Americas Inc.$570
- Sun Pharmaceutical Industries Inc.$296
- Johnson & Johnson Vision Care, Inc.$234
- plus $824 from 8 others
What the payments were for
- Food & beverage$4,347100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 22 | $1,190 |
| Coopervision Inc. | 27 | $620 |
| Alcon | 20 | $612 |
| Bausch & Lomb Americas Inc. | 12 | $570 |
| Sun Pharmaceutical Industries Inc. | 8 | $296 |
| Johnson & Johnson Vision Care, Inc. | 12 | $234 |
| Sight Sciences, Inc. | 3 | $153 |
| Mallinckrodt Hospital Products Inc. | 4 | $138 |
| Zimmer Biomet | 1 | $137 |
| Oyster Point Pharma, Inc. | 2 | $97 |
| Dompe US, Inc. | 2 | $91 |
| Glaukos Corporation | 1 | $85 |
| Aerie Pharmaceuticals, Inc. | 1 | $74 |
| AbbVie | 3 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOTRUE$493
- BIOTRUE ONE DAY$485
- ULTRA$368
- RIBFIX TITAN$137
- OMNI(R) SURGICAL SYSTEM (US)$115
- LOTEMAX SM$100
How this compares
$4,347 in reported general payments places this provider in the 90th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 159 | $1,683 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 14 | $729 |
| Prednisolone Acetate | 11 | $412 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 33 | $367 |
| Doxycycline Monohydrate | 17 | $256 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $194 |
| Ofloxacin | 21 | $191 |
| Brimonidine Tartrate | 14 | $108 |
| Timolol Maleate | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Blue Springs
- Anthony VerachtertKansas City$959K
- Joseph CastellanoSaint Louis$369K
- Richard WilsonRaytown$355K
- Lawrence ReedRaytown$317K
- Andrew BiondoKirkwood$300K
- Nicholas CastellanoSaint Louis$171K
- Geoffrey PowellKansas City$154K
- John McGrealSaint Louis$126K
- Erin SullivanSaint Louis$118K
- Jeffrey HarterRaytown$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.